James P Thomas

Ohio State University

$2,721,539

Attributed

$4,403,682

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $824.3K · FY2012–21

$1M$750K$500K$250K$0

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$4,403,682 · 2

By mechanism

P30$2,385,110 · 1

UG1$2,018,572 · 1

Top collaborators

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsTrainingFundingClinical TrialsEnsureMissionResourcesConduct Clinical TrialsResearch PersonnelBiometryCancer CenterClinical ResearchOperationGrowthLeadershipPositioning AttributeAdverse EventGenderCancer Center Support GrantGeneral PopulationClinical ProtocolsClinical NursingEthnicity AspectsClinical Investigator

Grant awards (7)

MCW NCTN Lead Academic Participating Site$824,283

UG1 · FY2021 · CA

MCW NCTN Lead Academic Participating Site$595,016

UG1 · FY2020 · CA

MCW NCTN Lead Academic Participating Site$599,273

UG1 · FY2019 · CA

Clinical Trials Office$614,853

P30 · FY2015 · CA · contact PI

Clinical Trials Office$591,101

P30 · FY2014 · CA · contact PI

Clinical Trials Office$569,771

P30 · FY2013 · CA · contact PI

Clinical Trials Office$609,385

P30 · FY2012 · CA · contact PI